In vitro performance testing of the novel Medspray wet aerosol inhaler based on the principle of Rayleigh break-up

Pharm Res. 2008 May;25(5):1186-92. doi: 10.1007/s11095-007-9503-1. Epub 2007 Dec 8.

Abstract

Purpose: A new inhaler (Medspray) for pulmonary drug delivery based on the principle of Rayleigh break-up has been tested with three different spray nozzles (1.5; 2.0 and 2.5 mum) using aqueous 0.1% (w/w) salbutamol and 0.9% (w/w) sodium chloride solutions.

Materials and methods: Particle size distributions in the aerosol were measured with the principles of time of flight (APS) and laser diffraction (LDA).

Results: The Medspray inhaler exhibits a highly constant droplet size distribution in the aerosol during dose emission. Droplets on the basis of Rayleigh break-up theory are monodisperse, but due to some coalescence the aerosols from the Medspray inhaler are slightly polydisperse. Mass median aerodynamic diameters at 60 l.min(-1) from APS are 1.42; 1.32 and 1.27 times the theoretical droplet diameters (TD's) and median laser diffraction diameters are 1.29; 1.14 and 1.05 times TD for 1.5; 2.0 and 2.5 mum nozzles (TD: 2.84; 3.78 and 4.73 mum respectively).

Conclusions: The narrow particle size distribution in the aerosol from the Medspray is highly reproducible for the range of flow rates from 30 to 60 l.min(-1). The mass median aerodynamic droplet diameter can be well controlled within the size range from 4 to 6 mum at 60 l.min(-1).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aerosols*
  • Albuterol / chemistry
  • Lasers
  • Microscopy, Electron, Scanning
  • Nebulizers and Vaporizers*
  • Particle Size
  • Sodium Chloride
  • Solutions

Substances

  • Aerosols
  • Solutions
  • Sodium Chloride
  • Albuterol